MTD director granted 162 options at $1,445.06; acquired 63 shares
Mettler-Toledo International (MTD) reported a director’s Form 4 showing equity awards on 11/11/2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Mettler-Toledo International (MTD) reported a director’s Form 4 showing equity awards on 11/11/2025. The filing lists the acquisition of 63 shares of common stock at a reported $0, bringing directly held common shares to 295 after the transaction. It also records a grant of stock options for 162 shares with an exercise price of $1,445.06. These options begin to vest in two equal annual installments starting on the first anniversary of the grant, are first exercisable on 11/11/2026, and expire on 11/11/2035. Following the grant, 162 options are beneficially owned.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 162 | $0.00 | $0.00 |
| Grant/Award | Common Stock, par value $0.01 per share | 63 | $0.00 | $0.00 |
Footnotes (1)
- F1. The options vest annually in two equal installments beginning on the first anniversary of the date of grant.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MTD disclose in this Form 4?
What are the key terms of the MTD stock option grant?
How do the MTD options vest?
How many options are beneficially owned after this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.